Table 2.
Mean parameters for simplified human PBPK models for caffeine, warfarin, omeprazole, metoprolol, and midazolam calculated from parameters in humanized mice, marmosets, cynomolgus monkey, dog, and minipig models.
probe drug | PBPK model | absorbed × intestinal availability, FaFg | absorption rate constant, ka (1/h) | distribution volume, V1 (L) | hepatic intrinsic clearance, CLh,int, in vivo (L/h) | hepatic clearance, CLh (L/h) | AUClast, ng h−1 mL−1 |
---|---|---|---|---|---|---|---|
caffeine | human, from humanized mice | 1 | 0.50 | 18.6 | 4.91 | 4.35 | 26200 |
human, average (± SD) | 1 | 0.97 (± 0.57) | 58.1 (± 29.4) | 7.25 (± 1.71) | 4.83 (± 2.52) | 16700 (± 6000) | |
literature | 21,300 (± 9,530) | ||||||
S-warfarin | human, from humanized mice | 1 | 7.51 | 5.90 | 2.54 | 0.259 | 17000 |
human, average (± SD) | 1 | 2.74 (± 3.03) | 9.7 (± 4.4) | 2.90 (± 2.41) | 0.25 (± 0.26) | 13900 (± 3380) | |
literature | 16,000 (± 4,340) | ||||||
omeprazole | human, from humanized mice | 1 | 2.84 | 77.2 | 2020 | 52.2 | 229 |
human, average (± SD) | 1 | 2.59 (± 1.84) | 37.2 (± 26.9) | 1340 (± 513) | 40.9 (± 9.9) | 407 (± 216) | |
literature | 368 (± 250) | ||||||
metoprolol | human, from humanized mice | 1 | 1.65 | 174 | 105 | 46.5 | 1300 |
human, average (± SD) | 1 | 0.91 (± 0.48) | 200 (± 66) | 178 (± 110) | 55.9 (± 10.6) | 939 (± 347) | |
literature | 449 (± 303) | ||||||
midazolam | Human, from humanized mice | 1 | 2.37 | 62 | 475 | 31.7 | 53.5 |
Human, average (± SD) | 1 | 1.00 (± 0.82) | 71 (± 33) | 827 (± 352) | 41.5 (± 10.4) | 37.5 (± 17.4) | |
Literature | 23.7 (± 8.0) |